These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23807486)

  • 21. Molecular basis and thrombotic manifestations of antithrombin deficiency in 15 unrelated Chinese patients.
    Ding Q; Wang M; Xu G; Ye X; Xi X; Yu T; Wang X; Wang H
    Thromb Res; 2013 Sep; 132(3):367-73. PubMed ID: 23932013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular analysis and genotype-phenotype correlation in patients with antithrombin deficiency from Southern Italy.
    Castaldo G; Cerbone AM; Guida A; Tandurella I; Ingino R; Tufano A; Ceglia C; Di Minno MN; Ruocco AL; Di Minno G
    Thromb Haemost; 2012 Apr; 107(4):673-80. PubMed ID: 22398878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Advances in the molecular biological study of hereditary antithrombin III deficiency].
    Chui H; Wang H
    Zhonghua Xue Ye Xue Za Zhi; 1998 Mar; 19(3):162-4. PubMed ID: 11243148
    [No Abstract]   [Full Text] [Related]  

  • 24. Genetic analysis should be included in clinical practice when screening for antithrombin deficiency.
    Zeng W; Tang L; Jian XR; Li YQ; Guo T; Wang QY; Liu H; Wu YY; Cheng ZP; Hu B; Lu X; Yu JM; Deng J; Wang HF; Sun CY; Yang Y; Hu Y
    Thromb Haemost; 2015 Feb; 113(2):262-71. PubMed ID: 25298121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel SERPINC1 missense mutation (Cys462Tyr) causes disruption of the 279Cys-462Cys disulfide bond and leads to type Ⅰ hereditary antithrombin deficiency.
    Zhang F; Gui Y; Lu Y; Liu D; Chen H; Qin X; Li S
    Clin Biochem; 2020 Nov; 85():38-42. PubMed ID: 32745482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Massive muscle haematoma three months after starting vitamin K antagonist therapy for deep-vein thrombosis in an antithrombin deficient patient: another case of factor IX propeptide mutation.
    Jahns M; Friess D; Demarmels Biasiutti F; Kremer Hovinga JA; Alberio L; Oldenburg J; Lämmle B; Colucci G
    Thromb Haemost; 2011 Aug; 106(2):381-2. PubMed ID: 21655682
    [No Abstract]   [Full Text] [Related]  

  • 27. Molecular bases of antithrombin deficiency: twenty-two novel mutations in the antithrombin gene.
    Picard V; Nowak-Göttl U; Biron-Andreani C; Fouassier M; Frere C; Goualt-Heilman M; de Maistre E; Regina S; Rugeri L; Ternisien C; Trichet C; Vergnes C; Aiach M; Alhenc-Gelas M
    Hum Mutat; 2006 Jun; 27(6):600. PubMed ID: 16705712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a New Mechanism of Antithrombin Deficiency Hardly Detected by Current Methods: Duplication of SERPINC1 Exon 6.
    de la Morena-Barrio B; de la Morena-Barrio ME; Padilla J; Teruel-Montoya R; Asenjo S; Wypasek E; Undas A; Miñano A; Vicente V; Corral J
    Thromb Haemost; 2018 May; 118(5):939-941. PubMed ID: 29564838
    [No Abstract]   [Full Text] [Related]  

  • 29. Antithrombin Cambridge II(A384S) mutation frequency and antithrombin activity levels in 120 of deep venous thrombosis and 150 of cerebral infarction patients in a single center in Southern China.
    Zhang GS; Tang YM; Tang MQ; Qing ZJ; Shu C; Tang XQ; Deng MY; Tan LM
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):588-91. PubMed ID: 20683322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in the shutter region of antithrombin result in formation of disulfide-linked dimers and severe venous thrombosis.
    Corral J; Huntington JA; González-Conejero R; Mushunje A; Navarro M; Marco P; Vicente V; Carrell RW
    J Thromb Haemost; 2004 Jun; 2(6):931-9. PubMed ID: 15140129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel mutation of SERPINC1 in a patient presenting as recurrent cerebral sinus venous and portal vein thrombosis.
    Teng XY; Han Y; Yin L; Xu FF; Liu ZJ
    Blood Coagul Fibrinolysis; 2020 Apr; 31(3):229-232. PubMed ID: 31990753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update.
    Rodgers GM
    Thromb Haemost; 2009 May; 101(5):806-12. PubMed ID: 19404531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antithrombin gene mutation 5356-5364*delCTT with type I deficiency and early-onset thrombophilia and a brief review of the antithrombin alpha-helix D molecular pathology.
    Steiner M; Steiner B; Rolfs A; Wangnick M; Burstein C; Freund M; Schuff-Werner P
    Ann Hematol; 2005 Jan; 84(1):56-8. PubMed ID: 15309521
    [No Abstract]   [Full Text] [Related]  

  • 34. A novel splice-site mutation c.42-2A>T (IVS1-2A>T) of SERPINC1 in a Korean family with inherited antithrombin deficiency.
    Jang MJ; Lee JG; Chong SY; Huh JY; Jang MA; Kim HJ; Oh D
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):742-5. PubMed ID: 21885952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thr90Ser Mutation in Antithrombin is Associated with Recurrent Thrombosis in a Heterozygous Carrier.
    Lu Y; Villoutreix BO; Biswas I; Ding Q; Wang X; Rezaie AR
    Thromb Haemost; 2020 Jul; 120(7):1045-1055. PubMed ID: 32422680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antithrombin: molecular basis of deficiency.
    Bayston TA; Lane DA
    Thromb Haemost; 1997 Jul; 78(1):339-43. PubMed ID: 9198176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombin Nagasaki (Ser 116 to Pro): a rare antithrombin variant with abnormal heparin binding presenting during pregnancy.
    O'Ddonnell JS; Hinkson L; McCarthy A; Manning R; Khan A; Laffan MA
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):217-20. PubMed ID: 16575261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel nonsense mutation in the antithrombin III gene (Cys-4-->stop) causing recurrent venous thrombosis.
    Saleun S; De Moerloose P; Bura A; Aiach M; Emmerich J
    Blood Coagul Fibrinolysis; 1996 Jul; 7(5):578-9. PubMed ID: 8874869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. β-Antithrombin, subtype of antithrombin deficiency and the risk of venous thromboembolism in hereditary antithrombin deficiency: A family cohort study.
    Croles FN; Mulder R; Mulder AB; Lukens MV; Meijer K
    Thromb Res; 2018 Aug; 168():47-52. PubMed ID: 29902631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two Novel Mutations Cause Hereditary Antithrombin Deficiency in a Chinese Family.
    Zhang H; Liu S; Luo S; Jin Y; Yang L; Xie H; Pan J; Wang M
    Acta Haematol; 2020; 143(3):260-265. PubMed ID: 31480053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.